Access cutting-edge atrial fibrillation treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access atrial fibrillation specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atrial fibrillation treatment provided free
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their ba
Sponsor: Icahn School of Medicine at Mount Sinai
Check if you qualify for this atrial fibrillation clinical trial in Stanford, CA
If you're searching for atrial fibrillation treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.